- Home
- HCKT vs ETON Comparison
HCKT vs ETON Comparison
Compare HCKT & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCKT | ETON |
|---|---|---|
| Founded | 1991 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 492.7M | 498.8M |
| IPO Year | 1998 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HCKT | ETON |
|---|---|---|
| Price | $20.60 | $15.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $27.00 | ★ $29.67 |
| AVG Volume (30 Days) | ★ 401.9K | 277.8K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $303,482,000.00 | $70,316,000.00 |
| Revenue This Year | $0.07 | $113.27 |
| Revenue Next Year | N/A | $36.70 |
| P/E Ratio | $52.05 | ★ N/A |
| Revenue Growth | 0.91 | ★ 102.77 |
| 52 Week Low | $17.53 | $11.09 |
| 52 Week High | $34.02 | $23.00 |
Technical Indicators
Market Signals| Indicator | HCKT | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 68.38 | 41.11 |
| Support Level | $19.60 | $16.13 |
| Resistance Level | $20.41 | $17.19 |
| Average True Range (ATR) | 0.51 | 0.73 |
| MACD | 0.18 | 0.07 |
| Stochastic Oscillator | 97.45 | 31.94 |
Price Performance
Historical ComparisonAbout HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.